Phase 3 clinical trial for vaccine being developed by China begins in Pakistan
(WorldNews Pakistan)

The National Command and Operation Centre (NCOC) on Tuesday announced the launch of phase 3 clinical trials in Pakistan for a potential vaccine being developed by China`s CanSino Biologics for the novel coronavirus. Trials for phase 1 and 2 for the vaccine were held in China. Pakistan, under a public-private partnership between the National Institute of Health (NIH) and CanSino, is among the countries which will carry out phase 3, the NCOC statement said. The country`s drug regulator last month gave the go-ahead for the country`s...